Second Edition of Malaysia Guidance on Medical Device Distribution Records Open for Public Comment: Updated Supply Chain Record Requirements
Views:74
Time:2026-11-16 11:37:05


The Medical Device Authority (MDA) of Malaysia has released the second edition draft guidance document Distribution Records for public comment (Document No.: MDA/GD/0012). Revised based on the first edition issued in 2020, this guidance upgrades requirements for full supply chain distribution records, traceability management and responsibilities of relevant stakeholders. Industry feedback is now being collected, and the comment window will close soon. Medical device companies operating in Malaysia shall pay close attention.



原
文
链
接


https://portal.mda.gov.my/index.php/ms/pengumuman/1874-announcement-public-comment-second-edition-guidance-document-distribution-records

一、Basic Document Information



Issuing Authority: Medical Device Authority (MDA), Malaysia 

Document Name: Distribution Records 

Document No.: MDA/GD/0012 

Status: Draft for public comment 

Public Comment Period: 03 Nov 2026 – 18 Nov 2026


Note:This is a draft version. All clauses are not legally binding. Enterprises shall comply with the officially released version issued by MDA.
二、Key Revisions in This Version



This revision covers the entire medical device supply chain, including manufacturers, authorised representatives, importers, distributors and other market participants. The main updates are as follows:

(一)Full Scope of Application
This guidance applies to all medical devices placed on the Malaysian market. It covers the whole circulation chain including importation, warehousing, sales and delivery. All commercial entities in the supply chain shall establish a complete and traceable distribution record system.

(二)Further Refined Distribution Record Items
Compared with the old version, the second edition specifies the information to be retained in distribution records. It strengthens requirements for product identification information, transaction flow data, stock-in & stock-out records, storage conditions, delivery receipts and other documents to ensure traceability of each batch of devices.

(三)Special Record Requirements Added for Software as a Medical Device (SaMD)
For SaMD, new obligations are introduced to retain records of installation, configuration and delivery. In addition to regular sales documents, SaMD manufacturers shall keep records of software deployment, version delivery and customer configuration.

(四)Traceability of Implantable Devices Extended to Patient Level
Traceability requirements for implantable medical devices are upgraded. The distribution record chain is extended to healthcare facility and patient levels, enabling full traceability from import and distribution to clinical implantation, and improving traceability for adverse events and field corrective actions.

(五)Clarified Responsibilities of Market Stakeholders
Responsibilities of manufacturers, Malaysian authorised representatives, importers and distributors for record creation, retention, handover and inspection are further defined. The record retention period and compliance rules for record access are also specified.
三、Compliance Reminders for Export Enterprises



Plan internal process optimisation in advance:Even at draft stage, the revision reflects MDA’s regulatory trend. Companies are recommended to sort out UDI information, SaMD delivery documents, implantable device traceability ledgers, record retention periods and record transfer workflows between upstream and downstream supply chain partners.
Follow official release updates:Once the formal version takes effect, the compliance threshold for distribution records in Malaysia will rise. Inadequate record systems may trigger risks during post-market surveillance audits, market inspections and recall handling.
四、Conclusion



Malaysia is a key medical device market in Southeast Asia. MDA keeps strengthening post-market supply chain supervision for medical devices. The core objective of this second edition of Distribution Records is to realise end-to-end traceability. Chinese exporters shall keep track of regulatory updates, optimise internal supply chain documentation and record management systems in advance to mitigate compliance risks in Malaysia.For further enquiries, please contact Wiselink Group.

Contact Us
Fill Form
Whether you need more information or wish to cooperate with us, we will guide you through every step of the regulatory process. Subscribe to our newsletter for the latest global regulatory updates.